Navigation Links
Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
Date:8/10/2009

that predicted for a poor prognosis.

About Vion Pharmaceuticals

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving the quality of life of cancer patients worldwide by developing and commercializing innovative oncology therapeutics. Vion has two agents in clinical trials, Onrigin(TM) (laromustine) Injection and Triapine((R)). The FDA is reviewing a New Drug Application for Onrigin(TM) for remission induction treatment for patients sixty years of age or older with de novo poor-risk AML. Triapine((R)), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, particularly Onrigin(TM) (laromustine) Injection (formerly Cloretazine((R) )(VNP40101M)), delays in the regulatory approval process, particularly for Onrigin(TM) (laromustine) Injection, including possible delays in the FDA's review process beyond our expectation for approval in December 2009, delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not confirmed by safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access cap
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices of ... took that commitment to a whole new level with the ... easier for existing and potential clients to contact the law ... added value to the firm’s services, #Dan covers Central Florida, ... law offices. , “I knew the pound sign (#) could ...
(Date:4/27/2015)... Texas has saved $433 million by converting their ... drug offenders with addiction treatment, according to an article ... states, including Massachusetts, are considering adopting justice reinvestment policies ... community recovery programs to help redress rampant addiction among ... Governments WA, ID, NE, KS, MI, PA, WV, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Climate change ... accuracy depends on the number of variables used and ... two noted scientists, water researcher Gerald Pollack, PhD, and ... Hour™ Power of Water® radio show, noted three potential ... , None of these individuals dispute that Earth’s ...
(Date:4/27/2015)... NZ (PRWEB) April 27, 2015 ... enhancement to their suite of mobile speech productivity ... and iOS tablets and smartphones. , ... Mobile Operating System since 2005. With the ... Winscribe’s fourth generation mobile application interface in the ...
(Date:4/27/2015)... 2015 PREVENT Life Safety, America’s premier ... operations with the addition of an account manager in ... to a growing customer base, Curtis Rice, an experienced ... Senior Account Manager. Curtis has been added to the ... throughout the Houston area and beyond. , ...
Breaking Medicine News(10 mins):Health News:Dan Newlin Hashtags It With #Dan 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 2Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 3Health News:Winscribe Professional Dictation for Smartphones Evolves as Microsoft’s Mobile OS Grows 4Health News:PREVENT Life Safety Services Welcomes Curtis Rice as a New Senior Account Manager in Houston, TX 2
... participated in the Flexidesc project by specifying a furnishing concept ... to devise a home that is accessible and adapted to ... having to move out of their homes owing to physical ... with the company SELLEX and the Matia Institute for Gerontology ...
... inflammatory bowel disease (IBD) and other gastrointestinal (GI) disorders ... according to a new study in Clinical Gastroenterology ... Gastroenterological Association. "Our results show that significant ... paralleled the increased use of computed tomography imaging," said ...
... -- Doctors may fail to detect precancerous growths if ... a new study warns. On the day before ... food and to consume only clear liquids. They also ... previous research suggests that up to one-quarter of colonoscopy ...
... 2012)Beatrice Mintz, Ph.D., professor and Jack Schultz chair in basic ... the Ninth Annual AACR Award for Lifetime Achievement in Cancer ... 2012, held Sunday, April 1, at 8:15 a.m. CT in ... for Lifetime Achievement in Cancer Research was established in 2004 ...
... Although eight states boosted their sales taxes on cigarettes over ... of such increases by states compared to 2009, a new ... shows. One thing that smoking prevention experts know from ... go up, the CDC said. "Increasing cigarette excise ...
... NEW YORK, N.Y. Autism Speaks, the world,s leading autism ... and appointed leaders to immediately develop a new, coordinated strategy ... autism epidemic in the wake of a new report ... autism is now diagnosed in a staggering 1 in every ...
Cached Medicine News:Health News:Tecnalia develops a flexible system for resting for people with reduced mobility 2Health News:Patients with digestive disorders may receive high levels of X-ray radiation 2Health News:Inadequate Bowel Prep May Invalidate Colonoscopy 2Health News:Beatrice Mintz, Ph.D., receives ninth annual AACR Award for Lifetime Achievement in Cancer Research 2Health News:Beatrice Mintz, Ph.D., receives ninth annual AACR Award for Lifetime Achievement in Cancer Research 3Health News:States' Efforts to Boost Cigarette Taxes Slows: CDC 2Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 2Health News:Autism Speaks demands urgent response to the autism epidemic in new CDC prevalence estimates 3
(Date:4/25/2015)... 25, 2015  With the introduction of Elekta,s new ... radiosurgery are now available for more patients with a ... generation stereotactic radiosurgery system for the brain, integrates advanced ... the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell ... ESTRO Forum in Barcelona . ...
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching ... cronuts: 1-800 CONTACTS announces their new Apple Watch app which ... Two taps. New contacts. From your watch. ... also features LensGauge which helps keep track of how long ... reorder. "Since our inception, we,ve been dedicated to ...
(Date:4/24/2015)... , April 24, 2015  Perrigo Company plc ... its rejection of the unsolicited offer from Mylan NV ... the outstanding shares of Perrigo for $60.00 per share ... ordinary Perrigo share (the "Offer").  The ... per share significantly undervalued the Company and its future ...
Breaking Medicine Technology:New Leksell Gamma Knife to benefit more patients with brain disease 2New Leksell Gamma Knife to benefit more patients with brain disease 3Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
... The Barbara Ann Karmanos Cancer Institute announced today that its spin-off ... capital to start the commercialization process of SoftVue, an alternative to mammography. ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) , ... SoftVue is a tomographic ultrasound imaging and ...
... 24 Genzyme Corp. has signed a consent decree agreeing to correct manufacturing ... to the federal government $175 million in unlawful profits from the sale ... announced today. , , , ... , , ...
Cached Medicine Technology:Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 2Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 3Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 4Karmanos Cancer Institute's Delphinus Receives $8 Million in Venture Capital for Product Development of Breast Cancer Imaging Tool 5Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 2Genzyme Corp. Signs Consent Decree to Correct Violations at Allston, Mass., Manufacturing Plant and Give up $175 Million in Profits 3
... Studies have proven that the management of ... blood glucose levels is the most effective way ... comprehensive care aimed at maintaining or improving a ... complex and costly. , ,These have been ...
... requires making decisions about insulin dosages and ... decisions are guided by data from blood ... by the patterns that can be seen ... when the data is presented in organized ...
... Pumped Green Photocoagulator - Portable and rugged ... outpatient clinic, and operating room. Built to ... in the most demanding environments, the Novus ... A full line of accessories for ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: